-
Lawmakers are going to have a difficult time with this one as they are not technically up to date enough as a whole to comprehend how all of this works in my estimation. with understanding the algorithms of finance and the economy, Wall Street showed us that. Sad, but it is true and this...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-28-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, My Commentaries, healthcare, privacy, health insurance, Prescriptions, Congress, Hospitals, Blue Cross, Blue Shield, Venture Capital, Reserve Funds, Profits
-
Some issues are a result of still being paper driven as timely reports and real time information are not available, but they are not the only government agency in this scenario, only one of the most critical though. Also, some members of Congress don’t use computers either and felt uncomfortable...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-26-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Medical Records, Pharma, FDA, Congress, integration, CMS, Leavitt
-
I think this article somewhat speaks for itself and why reporting is important and this is probably not the last story we will hear on this. If government had wanted to track this, a data base reporting system could have been set up with applicable laws a long time ago requiring payments to be...
-
This is probably a good move to speed this process up since many pharmaceutical companies have and are looking at moving more trials to India. More information can be read here about the changing face of Pharma in reference to research and development. One more area to think about too is the use...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-19-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Cancer, clinical trials, Congress, DNA Testing, National Cancer Institute, Justice Department
-
Genomics is back on the list for Congress, with creating an additional new agency and a focus on collecting the necessary information to allow research and development. Also included would be guidelines and rules related to genetic and pharmacogenomic tests to bring both Pharma and medical...
-
We all know this is one big job. We also need to bring Congress up to the 21st Century to get the job done too as we don't want the blind leading the blind. Stories in the past showed an FDA not aggressively enough seeking bigger budgets and reflecting back to a post in February, some of the top...
-
Discussed here is the recent law in Massachusetts relative to gifts, etc. just recently passed. Being the CEO of BIO, the biotech industry trade group, of course there's an interest in not having funds diminished, but also addresses the interest of the public. With all the recent Pharma...
-
The issues at hand goes back to 2006 with deviations from specifications on drugs, and now it is up to the Congress and the FDA once more. Did the FDA knowingly allow suspected drugs to continue to be sold? Ranbaxy makes a lot of different generic drugs and there’s no mention of the ones...
-
Congress and the Department of Justice now join the inquiry about the FDA actions investigating the alleged falsification of test records. This is where joint committees could also stand to shed some light here as both Australia and the UK are working with the FDA in reference to drug factories...
-
This is a must watch and read! Last week I posted the coverage from Robert Scoble interviewing Representative Culberson. There are a few using technology on Capitol Hill and the Congressman wants to use it to keep in touch with constituents and keeping everyone updated in real time. ...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
07-13-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, My Commentaries, BlackBerry, Congress, Twitter, Scoble, Qik, Culberson
-
By comparison, small bonuses were paid to scientists and doctors. $35 million in bonuses all together were handed out. The head of the criminal investigation division made more than the director of the FBI and the person in charge of revising the bonus system, well, they got the biggest bonus...
-
The basis of the current affairs of the FDA are not unlike many other stories being told today. We live in a world of transparency, and we are all still getting used to it for that matter, but things don’t fit under the carpet anymore. The old saying of “if it isn’t broke, don’t fix it”...